About SeqOne
SeqOne is a company based in Montpellier (France) founded in 2017. SeqOne has raised $48.79 million across 3 funding rounds from investors including Bpifrance, Software Club and Omnes Capital. SeqOne has completed 1 acquisition, including Congenica. SeqOne offers products and services including SeqOne Platform, DiagAI Score, and SeqOne Flow. SeqOne operates in a competitive market with competitors including Helix, Benchling, Genomics, BioAge Labs and Seven Bridges Genomics, among others.
- Headquarter Montpellier, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SeqOne
SeqOne offers a comprehensive portfolio of products and services, including SeqOne Platform, DiagAI Score, and SeqOne Flow.
AI-powered tool for NGS bioinformatics and data processing
System for identifying and prioritizing genetic variants
Automates genomic data transfer and analysis workflows
Funding Insights of SeqOne
SeqOne has successfully raised a total of $48.79M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $22.73 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SeqOne
SeqOne has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Software Club and Omnes Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Locked | Locked | Locked | |
|
Pivate equity firm that focuses on investing in healthcare and nutrition companies
|
Locked | Locked | Locked | |
|
Venture capital firm focused on early-stage investments
|
Locked | Locked | Locked |
Investor details for SeqOne
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SeqOne
SeqOne has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Congenica.
Investment portfolio details for SeqOne
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical genome analytics platform is offered for genetic disease treatment.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for SeqOne
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SeqOne
Detailed financials for SeqOne
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seqone Comparisons
Peer comparison for SeqOne
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SeqOne
SeqOne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genomics, BioAge Labs and Seven Bridges Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
Detailed competitors of SeqOne
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seqone
Complete news archive for SeqOne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SeqOne
SeqOne was founded in 2017 and raised its 1st funding round 2 years after it was founded.
SeqOne is headquartered in Montpellier, France. It is registered at Montpellier, Occitanie, France.
Nicolas Philippe is the current CEO of SeqOne.
SeqOne is a funded company, having raised a total of $48.79M across 3 funding rounds to date.
SeqOne was founded in 2017 in Montpellier, France, as a provider of bioinformatics tools focused on genome sequencing data analysis. The platform is used by researchers to detect and identify genetic variants, including SNPs, Indels, CNVs, and mid-sized deletions, that contribute to gene mutations. Operations center on supporting genomic research in the biotechnology sector through specialized software solutions.
SeqOne's top competitors include Helix, Tessera Therapeutics and Benchling.
SeqOne offers SeqOne Platform, DiagAI Score, and SeqOne Flow.
SeqOne has made 1 acquisition, including Congenica.
SeqOne has 8 investors. Key investors include Bpifrance, Software Club, Omnes Capital, Merieux Equity Partners, and Elaia.